Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 04
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
201,042
+4.28%
|
$1,206,252
$6.84 P/Share
|
|
Oct 02
2021
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,137
-3.69%
|
$48,891
$43.8 P/Share
|
|
Oct 02
2021
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
3,393
+9.91%
|
-
|
|
Oct 01
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Open market or private sale
|
Direct |
700
-5.2%
|
$30,100
$43.49 P/Share
|
|
Sep 15
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,321
-1.98%
|
$146,124
$44.88 P/Share
|
|
Sep 07
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
201,041
-8.81%
|
$8,845,804
$44.57 P/Share
|
|
Sep 07
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
201,041
+4.28%
|
$1,206,246
$6.84 P/Share
|
|
Sep 01
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Open market or private sale
|
Direct |
728
-3.44%
|
$32,760
$45.33 P/Share
|
|
Aug 31
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Bona fide gift
|
Direct |
135
-0.1%
|
-
|
|
Aug 30
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Bona fide gift
|
Direct |
183
-0.14%
|
-
|
|
Aug 16
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,322
-1.94%
|
$146,168
$44.3 P/Share
|
|
Aug 10
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+18.85%
|
$260,000
$13.08 P/Share
|
|
Aug 05
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Open market or private sale
|
Direct |
41,741
-38.7%
|
$1,836,604
$44.14 P/Share
|
|
Aug 03
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-3.98%
|
$39,420
$45.54 P/Share
|
|
Aug 03
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,973
+8.22%
|
-
|
|
Aug 02
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Open market or private sale
|
Direct |
727
-3.5%
|
$32,715
$45.77 P/Share
|
|
Aug 02
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
201,043
-8.81%
|
$9,046,935
$45.74 P/Share
|
|
Aug 02
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
201,043
+4.28%
|
$1,206,258
$6.84 P/Share
|
|
Jul 27
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
9,673
-27.31%
|
$43,528,500
$4500.0 P/Share
|
|
Jul 27
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+10.71%
|
$55,250
$13.08 P/Share
|
|
Jul 27
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
6,748
-4.82%
|
$303,660
$45.22 P/Share
|
|
Jul 27
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
105,490
-34.13%
|
$4,747,050
$45.0 P/Share
|
|
Jul 27
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
70,306
+18.53%
|
$421,836
$6.28 P/Share
|
|
Jul 27
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Open market or private sale
|
Direct |
13,850
-41.98%
|
$623,250
$45.01 P/Share
|
|
Jul 27
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
13,850
+29.57%
|
$318,550
$23.41 P/Share
|
|
Jul 27
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Open market or private sale
|
Direct |
728
-3.39%
|
$32,760
$45.0 P/Share
|
|
Jul 23
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Open market or private sale
|
Direct |
11,348
-34.54%
|
$499,312
$44.0 P/Share
|
|
Jul 23
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
11,348
+15.11%
|
$158,872
$14.7 P/Share
|
|
Jul 15
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,321
-1.9%
|
$139,482
$42.42 P/Share
|
|
Jul 06
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
201,041
-8.81%
|
$8,644,763
$43.41 P/Share
|
|
Jul 06
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
201,041
+4.28%
|
$1,206,246
$6.84 P/Share
|
|
Jul 01
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
214
-0.74%
|
$9,202
$43.36 P/Share
|
|
Jul 01
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
728
+2.45%
|
-
|
|
Jul 01
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
874
-6.28%
|
$37,582
$43.36 P/Share
|
|
Jul 01
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Open market or private sale
|
Direct |
700
-4.79%
|
$29,400
$42.78 P/Share
|
|
Jul 01
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,771
+10.81%
|
-
|
|
Jul 01
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
251
-1.34%
|
$10,793
$43.36 P/Share
|
|
Jul 01
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
855
+4.38%
|
-
|
|
Jun 24
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Open market or private sale
|
Direct |
16,450
-47.99%
|
$723,800
$44.03 P/Share
|
|
Jun 24
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
16,450
+32.43%
|
$279,650
$17.26 P/Share
|
|
Jun 16
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Open market or private sale
|
Direct |
8,833
-23.83%
|
$370,986
$42.76 P/Share
|
|
Jun 15
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,322
-1.87%
|
$139,524
$42.7 P/Share
|
|
Jun 15
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Open market or private sale
|
Direct |
7,901
-17.57%
|
$331,842
$42.78 P/Share
|
|
Jun 15
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,901
+14.95%
|
$94,812
$12.89 P/Share
|
|
Jun 14
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Open market or private sale
|
Direct |
5,000
-11.89%
|
$210,000
$42.94 P/Share
|
|
Jun 14
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.62%
|
$65,000
$13.08 P/Share
|
|
Jun 03
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
1,654
-44.57%
|
$67,814
$41.36 P/Share
|
|
Jun 01
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-2.23%
|
$29,232
$42.93 P/Share
|
|
Jun 01
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,762
+5.35%
|
-
|
|
Jun 01
2021
|
Edward F Mackey EVP, Operations |
SELL
Open market or private sale
|
Direct |
68,173
-74.19%
|
$2,863,266
$42.71 P/Share
|